Dr Raman Narang – Medical Oncologist in Delhi | Precision Oncology Specialist
Dr Raman Narang is a consultant medical oncologist in Delhi specializing in precision oncology, cancer genetics, immunotherapy, and personalized cancer treatment. He focuses on evidence-based care tailored to each patient’s biology, stage, and overall health profile.
Featured in: Financial Express • Hindustan Times • Indian Express • Republic World
Precision Oncology & Personalized Cancer Treatment
Modern cancer care is no longer one-size-fits-all. Treatment decisions are guided by tumor biology, molecular profiling, and genetic markers to optimize outcomes while preserving quality of life.
Expertise in Immunotherapy and Targeted Therapy
Advanced therapies such as immunotherapy and targeted treatments are selected based on validated biomarkers, international guidelines, and individual patient factors.
Second Opinion in Cancer Care
A structured second opinion helps patients understand diagnosis, stage, and treatment options clearly before making critical decisions.
What Patients say ?
After consulting multiple doctors for my father’s lung cancer, we met Dr. Narang. He took the time to explain the importance of genetic testing before starting chemotherapy. This precision approach changed our entire treatment plan. We are grateful for his clarity and patience – Rajesh
SECOND OPINION & GENETIC TESTING
My mother, who is 78, was diagnosed with breast cancer. We were very worried about chemotherapy at her age. Dr. Raman assessed her fitness carefully and adjusted the doses. She completed her treatment with manageable side effects and is now doing well. – Vikram
GERIATRIC ONCOLOGY
We traveled from Patna to Delhi for cancer treatment. Dr. Narang’s team helped us coordinate appointments efficiently so we didn’t have to stay longer than necessary. His diagnosis was spot on, and he guided us honestly about what was needed. – Suresh
Comprehensive Cancer Care in Delhi
From initial consultation to ongoing treatment and survivorship planning, care is coordinated with multidisciplinary teams while maintaining personalized oversight.
Consultations available across Delhi NCR including Lajpat Nagar and Punjabi Bagh.
Learn more about Dr Raman Narang’s clinical philosophy and experience.
Frequently Asked Questions
1. What is precision oncology and how can it influence cancer treatment?
Precision oncology refers to tailoring cancer treatment based on the molecular and genetic characteristics of an individual’s tumor rather than relying only on the cancer’s location in the body. Through advanced molecular profiling and biomarker testing, treatments such as targeted therapy and immunotherapy can be selected more accurately for certain patients.
2. When should a patient consider a second opinion in cancer care?
A second opinion can be valuable at the time of diagnosis, before starting chemotherapy or immunotherapy, before major surgery, or when treatment recommendations differ. A structured review of pathology reports, imaging, staging, and molecular markers can sometimes refine treatment strategy and improve long-term outcomes.
3. What role do genetic mutations play in cancer development?
Some cancers are driven by specific genetic alterations within tumor cells, while others may arise due to inherited mutations that run in families. Identifying these genetic changes helps guide treatment decisions and may also inform screening strategies for family members.
4. What tests are used for molecular profiling in cancer?
Molecular profiling typically involves advanced laboratory tests on tumor tissue or blood samples that identify biomarkers such as gene mutations, protein expression, or other molecular signals. These tests can help determine whether targeted therapies or immunotherapy may be effective.
5. Which cancers benefit most from targeted therapy or immunotherapy?
Several cancers now have treatment options guided by biomarkers, including lung cancer, breast cancer, colorectal cancer, melanoma, and certain gynecologic cancers. However, the suitability of these therapies depends on specific molecular markers and clinical context.
6. What information should patients bring for an oncology consultation?
Patients are usually advised to bring biopsy or pathology reports, imaging scans (CT, MRI, PET), treatment summaries, and any molecular testing reports. A comprehensive review of these records allows a more structured and accurate assessment of treatment options.
7. Can genetic testing help assess cancer risk in families?
Yes. In certain families where cancers occur at younger ages or across multiple generations, genetic testing may identify inherited cancer syndromes. This information can help guide preventive screening, early detection strategies, and personalized risk management.
8. How can patients seek consultation or a structured second opinion?
Patients can seek consultation by scheduling an appointment for an in-person evaluation or sharing medical records for a structured review. This allows a detailed assessment of diagnosis, staging, and treatment options in the context of current evidence and precision oncology approaches.
9. Who is Dr Raman Narang and what is his area of specialization?
Dr Raman Narang is a Consultant Medical Oncologist based in Delhi with a clinical focus on precision oncology, cancer genetics, and biomarker-guided cancer treatment. His work involves evaluating cancer at the molecular level to guide treatment strategies such as targeted therapy, immunotherapy, and personalized treatment planning.
10. What cancers does Dr Raman Narang commonly treat?
Dr Raman Narang treats a broad range of solid tumors including lung cancer, breast cancer, gastrointestinal cancers, gynecologic cancers, liver cancer, and genitourinary cancers. His clinical approach emphasizes molecular profiling, biomarker-driven treatment selection, and evidence-based systemic therapy.
11. Does Dr Raman Narang provide precision oncology and molecular profiling guidance?
Yes. Precision oncology is an important component of modern cancer care. Dr Raman Narang evaluates molecular biomarkers, tumor genetics, and immunotherapy markers to help identify treatment options such as targeted therapies, immunotherapy, and personalized treatment sequencing when appropriate.